AI developer ORO discloses that North Korean hackers stole its cryptocurrency worth $630,000
ChainCatcher news: According to Protos, AI shopping agent developer ORO disclosed that it lost approximately $630,000 due to a suspected North Korean hacker attack. The attackers gained access to the ORO team by using a compromised Telegram account to send employees a fake Microsoft Teams link, tricking them into installing a malicious extension. After nearly a month of data theft, they stole 147,000 Alpha tokens on July 13. ORO is highly confident that the attack originated from North Korean hacking group Sapphire Sleet.
ORO also admitted to its own security oversight — due to inadequate hardware wallet support in the Bittensor protocol, the company “temporarily” set the owner’s key as a software wallet, violating its internal hardware wallet priority principle, which resulted in the key being stolen from a compromised computer. ORO stated that it is working with exchanges, law enforcement, and Bittensor ecosystem partners to recover the stolen assets, and emphasized that its subnet is operating normally, with other wallets, user data, and validator signing keys unaffected.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly

XRP Ledger adds account control feature, enabling enterprises to manage assets offline.

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
